Skip to main content

Table 2 Agreement between different kidney function estimators in diagnosing CKD stage 3–5 (kappa statistic and 95% confidence interval)

From: Chronic kidney diseases in mixed ancestry south African populations: prevalence, determinants and concordance between kidney function estimators

Estimator 1

Estimator 2

Men

Women

Total

Cockcroft-Gault

MDRD corrected

0.27 (0.13-0.40)

0.60 (0.52-0.68)

0.51 (0.44-0.58)

 

MDRD

0.57 (0.44-0.70)

0.52 (0.45-0.58)

0.53 (0.47-0.59)

 

CKD-EPI corrected

0.35 (0.20-0.47)

0.66 (0.58-0.74)

0.57 (0.49-0.64)

 

CKD-EPI

0.64 (0.52-0.76)

0.65 (0.59-0.72)

0.65 (0.59-0.71)

MDRD corrected

MDRD

0.46 (0.30-0.60)

0.41 (0.34-0.47)

0.42 (0.36-0.48)

 

CKD-EPI corrected

0.87 (0.71-0.97)

0.92 (0.87-0.96)

0.91 (0.86-0.95)

 

CKD-EPI

0.53 (0.34-0.70)

0.57 (0.49-0.65)

0.57 (0.50-0.64)

MDRD

CKD-EPI corrected

0.51 (0.35-0.64)

0.38 (0.32-0.45)

0.41 (0.34-0.47

 

CKD-EPI

0.85 (0.74-0.93)

0.78 (0.72-0.82)

0.79 (0.74-0.83)

CKD-EPI corrected

CKD-EPI

0.58 (0.43-0.73)

0.54 (0.46-0.61)

0.55 (0.48-0.62)

  1. CG, Cockcroft-Gault; CKD-EPI, Chronic Kidney Disease Collaboration Epidemiology; DBP, 4-v-MDRD, four variable Modification of Diet in Renal Disease.